Could a new therapy boost joy in Spanish-Speakers with depression?

NCT ID NCT07493369

Ongoing Symptom relief Sponsor: Southern Methodist University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a therapy called Positive Affect Treatment (PAT) for Spanish-speaking adults with depression, anxiety, and low positive affect (a lack of joy or interest). Twelve participants will attend 15 therapy sessions over about 4 months, focusing on pleasant activities, positive thinking, and savoring good experiences. The goal is to see if the therapy is feasible and acceptable, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Positive Affect Treatment (PAT) - a behavioral therapy involving pleasurable activities, cognitive exercises, and savoring techniques
What this could lead to: If successful, this could provide a new therapy option for Spanish-speaking individuals with depression and anxiety who struggle with low positive affect.
What could go wrong: This is a very small pilot study with only 12 participants and no control group, so results may not be generalizable. It is early-stage and focuses on feasibility, not proof of effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANHEDONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anhedonia anxiety anxiety disorder depressive disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANHEDONIA ANXIETY DEPRESSION IN ADULTS

Contacts and locations

Locations

Southern Methodist University

Dallas, Texas, 75205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.